Metabolic Barriers to Glioblastoma Immunotherapy

SIMPLE SUMMARY: Glioblastoma (GBM) is an aggressive brain tumor with limited prognosis despite multimodal treatment approaches. Various immunotherapies have been investigated to address the need for novel therapeutic options in GBM with limited success. Recently, alterations in the metabolism of can...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhary, Nikita, Osorio, Robert C., Oh, Jun Y., Aghi, Manish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000693/
https://www.ncbi.nlm.nih.gov/pubmed/36900311
http://dx.doi.org/10.3390/cancers15051519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000693/
https://www.ncbi.nlm.nih.gov/pubmed/36900311
http://dx.doi.org/10.3390/cancers15051519

Ejemplares similares